高盛-恒瑞医药(600276):宣布与百时美施贵宝达成150亿美元多资产双向合作-Hengrui Medicine(600276.SS):Announced US$15bn collaboration with BMS structured as a multi-asset,bi-directional partners-20260512【8页】

发表回复

后才能评论